Clinical Trials
2 trialsNCT07282548 2026-04-29
Study of Tazemetostat in Adults With Follicular Lymphoma Previously Treated With at Least Two Therapies
Ipsen
Withdrawn
NCT06313996 2026-03-18
A Study to Evaluate the Efficacy and Safety of Liso-cel Compared to Standard of Care in Adults With Relapsed or Refractory Follicular Lymphoma
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 3 Withdrawn